Brought to you by 
Innovative Metabolics takes in $5.5mm via Series A round
11 Jun 2007
Executive Summary
Anti-inflammatory device developer Innovative Metabolics (IMI) has raised $5.5mm in a Series A financing led by Morgenthaler Ventures. Foundation Medical Partners also participated.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Innovative Metabolics takes in $5.5mm via Series A round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice